Evidence map›Paper›PMID 23622250›Full record

ArticleCell2013

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

Bin Zhang, Chris Gaiteri, Liviu-Gabriel Bodea, Zhi Wang, Joshua McElwee, Alexei A Podtelezhnikov, Chunsheng Zhang, Tao Xie, Linh Tran, Radu Dobrin and 20 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06706947 (Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease), which is not on this map. Cited by 1,050 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,050citing papers in PubMed, 3 pooled it
52.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06706947 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease

TypeinterventionalSponsorLuo XinxinRan2024 to 2025Enrolled20ConditionsAlzheimer&amp, #39, s Disease (AD)ArmsLymphaticovenous Anastomosis
3 · Its place in the literature

Who cites it

1,050 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,750 citations in OpenAlex.

  1. Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Unveiling the pathogenesis and therapeutic strategies of Alzheimer's disease through cuproptosis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Integrative Transcriptomics and Mendelian Randomization IdentifyCurrent issues in molecular biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

990 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 3 countries.

Bin ZhangDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. bin.zhang@mssm.edu
Chris Gaiteri
Liviu-Gabriel Bodea
Zhi Wang
Joshua McElwee
Alexei A Podtelezhnikov
Chunsheng Zhang
Tao Xie
Linh Tran
Radu Dobrin
Eugene Fluder
Bruce Clurman
Stacey Melquist
Manikandan Narayanan
Christine Suver
Hardik Shah
Milind Mahajan
Tammy Gillis
Jayalakshmi Mysore
Marcy E MacDonald
John R Lamb
David A Bennett
Cliona Molony
David J Stone
Vilmundur Gudnason
Amanda J Myers
Eric E Schadt
Harald Neumann
Jun Zhu
Valur Emilsson
Merck & Co., Inc., Rahway, NJ, USA (United States) · USSage Bionetworks · USIcahn School of Medicine at Mount Sinai · USMassachusetts General Hospital · USUniversity of Bonn · DEIcelandic Heart Association · ISJohn Jay College of Criminal Justice · USNorth Seattle College · USRush University Medical Center · USUniversity of Iceland · ISUniversity of Miami · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Risk Factors for Incident Alzheimer's Disease in a Biracial CommunityR01AG011101 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 1993 to 2010
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Genetic Epidemiology of Cognitive Decline in an Aging Population SampleR01AG030146 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 2007 to 2018
$6.2M
GENETIC MODEL OF HUNTINGTONS DISEASER01NS032765 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MACDONALD, MARCY · 1994 to 2011
$3.7M
1/3-Networks from Multidimensional Data for Schizophrenia and Related DisordersR01MH097276 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHADT, ERIC E, SKLAR, PAMELA · 2012 to 2014
$2.5M
THE HUMAN BRAINOME:genome, transcriptome and proteome interaction in human cortexR01AG034504 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MYERS, AMANDA J · 2009 to 2012
$1.1M
Exploring the Genetics of Alzheimer's Disease in Humans and DrosophilaK08AG034290 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHULMAN, JOSHUA M · 2009 to 2013
$658k
NIA NIH HHS K08 AG034290NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG10161NIA NIH HHS R01 AG011101NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG034504NIA NIH HHS R01 AG11101NIA NIH HHS R01 AG15819NIA NIH HHS R01 AG17917NIMH NIH HHS R01 MH097276NINDS NIH HHS NS032765NINDS NIH HHS R01 NS032765
6 · The paper itself

Abstract

The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.

Indexed as

Gene Regulatory NetworksAdaptor Proteins, Signal TransducingAlzheimer DiseaseAnimalsBayes TheoremBrainHumansMembrane ProteinsMiceMicrogliaAdaptor Proteins, Signal TransducingMembrane ProteinsTYROBP protein, human

Identifiers

PMID23622250
PMCPMC3677161
OpenAlexW2033105784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.